What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?

Por Swart, Joost F, de Roock, Sytze, Wulffraat, Nico M
Publicado em 2013

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis

Por Swart, Joost F, van Dijkhuizen, E H Pieter, Wulffraat, Nico M, de Roock, Sytze
Publicado no Ann Rheum Dis (2018)

The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

Por Dehoorne, Joke, Joos, Rik, Wouters, Carine, Swart, Joost F., Consolaro, Alessandro, Bovis, Francesca, Ruperto, Nicolino
Publicado no Rheumatol Int (2018)

The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

Por Wulffraat, Nico, Kamphuis, Sylvia, Swart, Joost F., Vastert, Sebastiaan, Van Dijkhuizen, Pieter, van Pelt, Philomine, van Dijk-Hummelman, Annette, Consolaro, Alessandro, Bovis, Francesca, Ruperto, Nicolino
Publicado no Rheumatol Int (2018)